Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_provenance.
- befree-2016 importedOn "2016-02-19" NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_provenance.
- NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_assertion wasGeneratedBy ECO_0000203 NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_provenance.
- NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_assertion wasDerivedFrom befree-2016 NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_provenance.
- NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_assertion SIO_000772 24312257 NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_provenance.
- NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_assertion evidence source_evidence_literature NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_provenance.
- NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_assertion description "[Based on its previous efficacy in restenosis and kidney fibrosis we expected that the KCa3.1 blocker TRAM-34 would primarily affect smooth muscle and fibroblast proliferation and thus reduce intimal hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1134429.RA8KtX1LYLIlLMd1DT_tm1PSxDJ8xGy8NxNYK2bENOpJU130_provenance.